Physician profile
Babak Abai
NPI 1780883371
$36,792.90
in general payments reported to CMS, 2019-2025
37 companies · $6,247 in 2025
The $6,247 reported for 2025 was more than what 86% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,758 · 2020: $857 · 2021: $5,165 · 2022: $8,415 · 2023: $9,776 · 2024: $3,575 · 2025: $6,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $5,550 · Travel and Lodging: $3,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,228.69 |
| Consulting Fee | $5,550.00 |
| Travel and Lodging | $3,819.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $17,217.06 | 2019-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System, Torus Stent Graft System |
| Cook Medical LLC | $6,305.26 | 2019-2025 | Zenith Spiral-Z, Cook, Zenith Alpha |
| Bolton Medical INC | $5,151.16 | 2021-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| W. L. Gore & Associates, INC. | $1,314.44 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore-Tex Suture |
| Cook Incorporated | $1,020.00 | 2021 | |
| Silk Road Medical, INC. | $1,011.12 | 2019 | |
| Boston Scientific Corporation | $783.11 | 2019-2025 | Eluvia, General - Vascular Intervention |
| Medtronic, INC. | $780.89 | 2021-2025 | Endurant Iis, Hawkone |
| Medtronic Vascular, INC. | $542.17 | 2019-2020 | |
| Baxter Healthcare | $235.01 | 2021-2023 | Floseal |
| Abbott Laboratories | $216.43 | 2022-2025 | Xact, Perclose Prostyle, Thoratec Heartmate 3 Lvas Implant Kit |
| Penumbra, INC. | $197.96 | 2023-2025 | Penumbra System |
| Novartis Pharmaceuticals Corporation | $184.15 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $165.31 | 2021-2024 | Xarelto |
| Amgen INC. | $160.91 | 2019-2025 | Repatha |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $158.95 | 2025 | Pounce Thrombectomy System, Pounce LP Thrombectomy, Pounce Thrombectomy |
| Becton, Dickinson and Company | $144.90 | 2024 | Lutonix Drug Coated Balloon |
| Philips North America LLC | $142.00 | 2022 | |
| Angiodynamics, INC. | $126.52 | 2025 | Auryon Laser System 100-120 Vac |
| Shape Memory Medical INC. | $125.23 | 2025 | Impede Embolization Plug |
| Cvrx, INC. | $121.92 | 2024 | Barostim Neo System |
| Inari Medical, INC. | $80.63 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $76.97 | 2024-2025 | Wainua |
| Bridgebio Pharma, INC. | $72.71 | 2025 | Attruby |
| Abiomed | $70.28 | 2024 | Impella |
| Convatec INC. | $61.00 | 2024 | |
| Daiichi Sankyo INC. | $56.50 | 2022-2023 | Injectafer |
| Misonix INC | $55.28 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.14 | 2024-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $37.95 | 2023-2024 | Camzyos, Eliquis |
| Shockwave Medical, INC | $26.73 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heartflow, INC. | $23.40 | 2025 | |
| Edwards Lifesciences Corporation | $21.81 | 2024 | |
| Scpharmaceuticals INC. | $18.82 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $18.07 | 2022 | |
| Merck Sharp & Dohme LLC | $16.27 | 2023 | Verquvo |
| Pfizer INC. | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Abai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.